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Persistent accumulation of DNA damage induced by reac-
tive oxygen species (ROS) is proposed to be a major contrib-
utor toward the aging process. Furthermore, an increase in
age-associated ROS is strongly correlated with aging in vari-
ous species, including humans. Here we showed that the
enforced expression of the ROS modulator 1 (Romo1) trig-
gered premature senescence by ROS production, and this also
contributed toward induction of DNA damage. Romo1-de-
rived ROS was found to originate in the mitochondrial elec-
tron transport chain. Romo1 expression gradually increased
in proportion to population doublings of IMR-90 human
fibroblasts. An increase in ROS production in these cells with
high population doubling was blocked by the Romo1 knock-
down using Romo1 small interfering RNA. Romo1 knock-
down also inhibited the progression of replicative senes-
cence. Based on these results, we suggest that age-related
ROS levels increase, and this contributes to replicative senes-
cence, which is directly associated with Romo1 expression.
The chromosomal ends of senescent cells are associatedwith
DNA damage-response factors. Telomere shortening triggers a
DNA damage checkpoint response, resulting in replicative
senescence. Blocking of the DNA damage checkpoint response
releases cell cycle arrest in the G1 phase of the cell (1). One of
the important mediators in telomere-dependent senescence is
p53, and it plays an important role in DNA damage response as
well as regulation of cellular senescence. The other main regu-
lators of senescence are reported as p21WAF1/CIP1, p16INK4A,
and retinoblastoma protein, and these have been classified into
two major signaling pathways, the p53/p21WAF1/CIP1 pathway
and the p16INK4A/retinoblastoma protein pathway (2).
ROS3 are continuously produced in response to both endog-
enous and exogenous stimuli inside the cell (3). Even though
poor regulation of ROS production could lead to various path-
ological disorders, low levels of ROS are indispensable formany
biological processes such as mitogenic proliferation (4, 5). ROS
have been known to be the main mediator and inducer of cel-
lular senescence and organismal aging (6). Hydrogen peroxide
treatment of cells triggers senescence-like growth arrest, and
oxidative damage correlates with senescence of human fibro-
blast cells (7, 8). ROS induce cellular senescence not only by
triggering DNA damage but also by activating redox-sensitive
pathways (9). It was suggested that oxidative stress shortened
the telomere length through DNA single strand breaks (10).
Increased oxidants trigger oxidative DNA damage, and such
oxidants are sensed by the DNA damage-response pathway,
which is a common mediator of senescence (6). The oxidative
DNA damage in promoters of genes that are down-regulated
with age has been known to be associated with human brain
aging (11).
ROS are generated from the electron transport chain in the
mitochondria, which is themain source of ROS (3).Many stud-
ies have reported that ROS derived from the mitochondria are
directly involved in replicative senescence. Intracellular ROS
levels were increased with age, and this is associated withmito-
chondrial dysfunction (12). The down-regulation of genes
related to mitochondrial function was also observed in the
aging human brain (11). Mitochondrial dysfunction was
detected in hepatocytes from old rats, in which low mitochon-
drial membrane potential and increased ROS levels were
observed (13). In accordance with these results, Zahn et al. (14)
observed that genes involved in the mitochondrial electron
transport chain pathway are down-regulatedwith age in several
species, including humans.
Mitochondrial dysfunction is correlated with an accumula-
tion of mtDNA mutations, which contributes to aging and
degenerative diseases (15). Mutations and deletions of mtDNA
were observed during aging (16, 17). Increased mutations and
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deletions ofmtDNA inmicewith defectivemitochondrialDNA
polymerase are associated with reduced life span (18). There
have been many reports that gene mutations in the mitochon-
drial electron transport chain produce high levels of oxidants
and are correlatedwith aging. Increased superoxide production
was observed in the skin fibroblast containing complex I
(NADH-CoQ reductase) deficiency (19). Amutation in the suc-
cinate dehydrogenase cytochrome b large subunit in complex II
was reported to produce superoxide (20). The increased ROS
production resulting from this mtDNA mutation demon-
strated a role in life span (21). A mutation of the succinate
dehydrogenase cytochrome b subunit causes premature aging
in nematodes (21). Furthermore, the inactivation of the COX5
gene of the respiratory complex IV decreases ROS production
and prolongs life span (22). A mutation in the iron-sulfur pro-
tein (isp-1) also decreases sensitivity to ROS and increases the
life span (23). One other study also showed that the targeted
mutation of p66Shc extended the murine life span (24). p66Shc,
which is located in the mitochondria, produces mitochondrial
ROS in response to proapoptotic signals (25).
In accordance with the above studies, transgenic mice over-
expressing catalase in themitochondria extendmurine life span
(26). These results demonstrated that oxidative stress in the
mitochondria is associated with aging. However, no correlation
reports between mitochondrial ROS production and longevity
were also reported inDrosophila and Sod2/mice (27, 28). In
a previous study, we identified a novel protein termed Romo1,
which was shown to localize to the mitochondria. We also
showed that enforced Romo1 expression enhanced ROS pro-
duction (29). Through further investigation, we reported that
Romo1 was responsible for up-regulated ROS levels in cancer
cells and that Romo1-derived ROS was required for cancer cell
proliferation as well as normal cells such as IMR-90 human
fibroblasts (5). Because increased ROS levels and oxidative
damage are both implicated as the major contributors toward
senescence, this study was undertaken to investigate the
expression of Romo1 in senescent cells and whether Romo1-
derived ROS played a role in cellular senescence.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents—The human lung fibroblast
IMR-90 cell line was obtained from theAmerican TypeCulture
Collection (ATCC, Manassas, VA), and cells were maintained
in Eagle’s minimal essential media. Human lung cancer cells
(H1299) were cultured in RPMI 1640 medium (Invitrogen). All
media contained 10% heat-inactivated fetal bovine serum
(Invitrogen), sodium bicarbonate (2 mg/ml; Sigma), penicillin
(100 units/ml), and streptomycin (100 g/ml; Invitrogen).
2,7-Dichlorofluorescein diacetate (DCF-DA), N-acetylcys-
teine (NAC), H2O2, stigmatellin, myxothiazol, and rotenone
were purchased from Sigma. MitoSOX, dihydrorhodamine
123, MitoTracker Red, and 5,5,6,6-tetrachloro-1,1,3,3-
tetraethylbenzimidazolylcarbocyanine iodide (JC-1) were
obtained from Molecular Probes (Eugene, OR).
Senescence-associated (SA) -Galactosidase Assay—Cellular
senescence was examined using a senescent cell staining kit
(Sigma). SA--galactosidase staining was performed according
to the manufacturer’s instructions.
Small Interfering RNAAssay—Romo1 siRNAdesigned to tar-
getRomo1 (30)was synthesized by Bioneer (Taejon, Republic of
Korea) and was transfected into IMR-90 cells using Lipo-
fectamine 2000 (Invitrogen).
RNA Preparation and Northern Blotting—Total RNA was
extracted from each sample using TRIzol reagent (Invitrogen).
After 10 g of the total RNA was resolved on a 1% agarose/
formaldehyde gel, the RNA samples were transferred into a
Nytran N nylon membrane (Schleicher & Schuell). The Romo1
cDNAprobe (29)was labeledwith a randomprimerDNA label-
ing kit (Roche Applied Science). Hybridization was performed
overnight at 68 °C.
Measurement of Intracellular ROS by Flow Cytometry—The
fluorescence intensity of the DCF-DA-stained cells was meas-
ured by a FACScan flow cytometer (BD Biosciences). The cells
were cultured for 2 days in the presence of control siRNA or
Romo1 siRNAand then incubatedwith 50MDCF-DAat 37 °C
for 30 min, and intracellular fluorescence of 5,000 cells was
measured by flow cytometry using the green fluorescence emis-
sion parameter. ROS levels were alsomeasured using dihydror-
hodamine 123 (5 M) and MitoSOX (5 M).
Measurement of Mitochondrial Membrane Potential—To
determine changes of mitochondrial membrane potential after
Romo1 induction, H1299/pGene-Romo1 cells (29) treatedwith
mifepristone (MFP)were incubatedwith JC-1 (5M) for 30min
at 37 °C. JC-1 was excited at 490 nm, and emission fluorescence
was filtered, and images were collected at fluorescein isothio-
cyanate (green, 530 nm) and TRITC channels (red, 590 nm)
using the LSM510 (Zeiss). The images were analyzed using
LSM 3.5 image analysis software (Zeiss).
Western Blot Analysis—Western blotting was performed
using anti-p53 (DAKO, Denmark), anti-p21WAF1/CIP1 (Santa
Cruz Biotechnology), anti-p16INK4a (Santa Cruz Biotechnol-
ogy), and anti--actin (Sigma) antibodies as described previ-
ously (31). Blots were visualized using chemiluminescence
(ECL kit, Amersham Biosciences).
ROS Assays—For ROS measurement using SpectraMax
(Molecular Devices, Sunnyvale, CA), 2  104 cells were plated
onto 12-well plates. DCF-DA was added to cell culture media
and incubated at 37 °C for 30 min. After the cells were rinsed
with phosphate-buffered saline (PBS; pH7.4), intracellular ROS
levels were measured at a 490 nm excitation wavelength and at
a 535 nm emission wavelength using SpectraMax. ROS fluores-
cence intensity was normalized by the cell number, which was
counted using trypan blue staining.
FluorescenceMicroscopy—MitoSOX (5M)was added to cell
culturemedia, and excess probes were removed by rinsing with
PBS. Coverslips were wet-mounted onto slides, and fluorescent
images frommultiple fields of view were captured using a fluo-
rescence microscope (Olympus LX71 microscope).
Confocal Microscopy—After treatment, the cells grown on
the chambered cover glass were washed twice with PBS and
incubated with MitoTracker Red (50 nM). DCF-DA was added
directly to the cell cultures and incubated at 37 °C for 30min to
detect ROS. The fluorescence images from multiple fields of
viewwere obtained using anAxioplan IImicroscope (Zeiss) and
a confocal microscope (MRC-1024MP, Bio-Rad, and LSM510,
Zeiss), which were set at the designated exposure setting. For
Romo1-induced Senescence
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foci analyses, the cells were first fixed, permeabilized, and
blocked. The foci were observed by immunolocalization using
the anti-phospho-H2AX (1:200, Upstate Biotechnology) anti-
body diluted in 1% bovine serum albumin/PBS/Triton X-100.
The immune complexes were then stained with Alexa Fluor
594-conjugated goat anti-rabbit IgG (1:500,Molecular Probes).
After 4,6-diamidino-2-phenylindole staining and mounting,
fluorescence images were obtained using Zeiss Axioplan II and
confocal microscopy. The images were analyzed using LSM 3.5
image analysis software (Zeiss) andConfocalAssistant software
(version 4.02, Bio-Rad).
Analysis of DNA Damage by Alkali Comet Assay—The cells
were treated with either H2O2 (200 M) or IR (10 Gy), and the
H1299/pGene-Romo1 cells were induced by MFP. A Comet
Assay kit (Trevigen) was used according to the manufacturer’s
instructions. For the comet assay, electrophoresis was per-
formed at 1 V/cm and 30 mA for 60 min. The ratios of DNA in
the head and tail of the comets were
analyzed. Eighty randomly selected
cells per sample were examined.
Transmission Electron Micro-
scopy—The cells were cultured
until they reached 50% confluency
and were then treated with MFP for
24 h with or without NAC (0.5 mM).
The cells were washed twice with
PBS and centrifuged at 1,000 rpm
for 5min. The samples were fixed in
2% osmium tetroxide for 2 h, and
stained en blocwith a uranyl acetate
coloration solution for 90min.After
dehydration with increasing con-
centrations of ethanol and propyl-
ene oxide, thin sections were sliced
using the Reichert ultracut and
mounted on 200-mesh copper
grids. These were then stained with
2% uranyl acetate and 1% lead cit-
rate for 12 min each. The grids were
observed under a Hitachi H-7500
electron microscope, and images
were captured at a final magnifica-
tion of15,000.
Statistical Analysis—Each assay
was performed in triplicate and was
independently repeated at least
three times. Statistical analysis was
conducted using the Student’s anal-
ysis of variance. Statistical signifi-
cance was defined as p  0.05.
Means, S.E., and p values were cal-
culated using GraphPad PRISM,
version 4.02 for Windows (Graph-
Pad Software, San Diego).
RESULTS
Romo1 Expression Was Increased
in Senescent Cells—Romo1 was
reported to generate ROS in the mitochondria (29). Therefore,
we were curious as to whetherRomo1 expressionwas increased
during the progression of senescence of IMR-90 cells. Northern
hybridization was conducted to examine Romo1 expression in
these cells. Interestingly, Romo1 expression was enhanced in
the cells at PDL 51, and higher Romo1 expression was observed
in the cells at PDL 75 (Fig. 1A). Increased ROS formation was
observed in cultured endothelial cells with high PDL, and this
was concurrent with other studies reporting elevated ROS lev-
els with age (12, 32). We examined ROS levels in old IMR-90
cells. IMR-90 cells that had been continuously cultured were
stained with DCF-DA, and the ROS levels were examined by
confocal microscopy. Increased DCF-DA staining was
observed in the cells at PDL 55 (Fig. 1B), which corresponded to
increased ROS levels. The increased ROS formation was quan-
tified using a microfluorometer plate reader, and the relative
ROS increase is shown in Fig. 1C. ROS levels were also meas-
FIGURE 1. Increased Romo1 and ROS levels in IMR-90 cells with high PDL. A, Romo1 expression in IMR-90
cells with various PDL. To determine the Romo1 expression level in IMR-90 cells, Northern blot analysis was
performed by hybridization with a 245-bp 32P-labeled BamHI-XhoI fragment of Romo1 or human GAPDH
probe. B, IMR-90 cells (PDL 28 and PDL 55) were stained with MitoTracker or DCF-DA, and ROS levels were
determined by confocal microscopy. DAPI, 4,6-diamidino-2-phenylindole. C, ROS levels in IMR-90 cells with
various PDL were measured by SpectraMax using DCF-DA. Relative ROS levels were normalized by cell count-
ing using trypan blue. Results represent mean (S.E.) of three independent experiments performed in tripli-
cate. *, p 0.05 versus the IMR-90 (PDL 28) cells.D,ROS levels in cellsweremeasuredby fluorescence-activated
cell sorter analysis after stainingwith the fluorescent probes. The gray curves indicate IMR-90 cells with PDL 32,
and the red curve indicates IMR-90 cells with PDL 67. E, protein samples (30 g/ml) were separated using 12%
SDS-PAGE and transferred onto nitrocellulose membranes. Immunodetection was performed using anti-p53,
anti-p21WAF/CIP1, anti-p16INK4a, and anti--actin antibodies. A.U. refers to artificial units.
Romo1-induced Senescence
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ured by flow cytometry, and the same results were obtained, as
shown in Fig. 1D. The shift to the right of the curve because of
increased fluorescence indicated an increase in the intracellular
ROS levels. Because p53, p21WAF/CIP1, and p16INK4a expression
were enhanced in cells with high PDL (33, 34), this was exam-
ined by Western blot analysis. Fig. 1E showed that the expres-
sion of these proteins was gradually
up-regulated during continuous
culture of IMR-90 cells.
Romo1 Expression Was Responsi-
ble for ROS Increase in Senescent
Cells—We then tried to determine
whether Romo1-induced ROS was
responsible for ROS increase in cells
with high PDL. As shown in Fig. 2A,
enhanced ROS levels were observed
in IMR-90 cells at PDL 54, and
transfection with Romo1 siRNA
blocked this increase in ROS forma-
tion. The production of mitochon-
drial ROS in the IMR-90 cells was
quantified using the Metamorph
software (Fig. 2B). ROS reduction by
Romo1 siRNA was also observed by
flow cytometry (Fig. 2C). These
results demonstrated that Romo1
played amajor role in the regulation
of ROS in IMR-90 cells with high
PDL. IMR-90 cells, which are
human normal lung fibroblast cells,
are quite difficult to transiently
transfect with plasmids, and such
experiments are usually conducted
in the presence of a drug selection.
To observe the transfection effi-
ciency of IMR-90 cells, we examined
Romo1 knockdown byRT-PCR (Fig.
2D) and measured transfection effi-
ciency by flow cytometry (Fig. 2E).
Romo1 knockdown was conducted
by RT-PCR, but not by Northern
blot techniques, because of the low
expression of Romo1 expression
(29). Fig. 2E showed that Romo1
siRNA was efficiently transfected
into IMR-90 cells and that the trans-
fection efficiency of Romo1 siRNA
was greater than 60%.
Increased Romo1 Expression In-
duced Senescence—To test whether
Romo1 expression triggered cellular
senescence of IMR-90 cells, retrovi-
rus expressing Romo1 was infected
into the cells and treated with G418.
Ten days later, SA--galactosidase
activity was measured. As shown
in Fig. 3, A and B, Romo1 expres-
sion induced cellular senescence.
H-Ras was used as a positive control. Fig. 3C shows that
Romo1 expression enhanced intracellular ROS level, and
H-Ras also increased the cellular ROS level. Fig. 3C, right
column, shows the merged images of ROS and mitochondria
stained with MitoTracker. A hybrid gene encoding Romo1
tagged with Myc (Romo1-myc) was used in this experiment,
FIGURE 2. ROS down-regulation by Romo1 siRNA transfection. A, fluorescence microscopy images of ROS
down-regulation by Romo1 siRNA (100 nM) transfection. IMR-90 cells (PDL 33 and PDL 54) were stained with
MitoSOX (5M).DAPI, 4,6-diamidino-2-phenylindole. B,measurement ofmitochondrial ROS production. Data
were acquired and analyzed using Metamorph software (Universal Imaging, Westchester, PA). *, p  0.01.
C, IMR-90 cells (PDL 52) were transfected with Romo1 siRNA and stained with DCF-DA. ROS down-regulation
was analyzed by flow cytometry. D, Romo1 knockdown by Romo1 siRNA transfection in IMR-90 cells. Romo1
siRNA (100 nM) or control siRNA (100 nM) were transfected into IMR-90 cells, and the cells were harvested after
48 h. Romo1 knockdown was examined by RT-PCR. -Actin was used as a loading control. E, flow cytometric
analysis. Romo1 siRNA-fluorescein isothiocyanate was transfected into IMR-90 cells, and the transfection effi-
ciency was analyzed by flow cytometry. N, nontransfected cells; C, cells transfected with control siRNA; R, cells
transfected with Romo1 siRNA; RF, cells transfected with Romo1 siRNA-fluorescein isothiocyanate.
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and Romo1-myc protein expression
was examined byWestern blot anal-
ysis using the anti-Myc antibody
(29). These results demonstrated
that Romo1 expression was in-
creased during progression of cel-
lular senescence, and increased
Romo1 expression induced cellu-
lar senescence.
Next, we examined whether the
increase of Romo1-derived ROS
formation was associated with rep-
licative senescence of IMR-90 cells.
The cells were transfected with 40
nM Romo1 siRNA because 100 nM
Romo1 siRNA inhibited cell growth
(5). As shown in Fig. 4, Romo1
siRNA transfection delayed replica-
tive senescence. As a positive con-
trol, the cells were treated with
NAC. NAC treatment inhibited
replicative senescence, and this
result was consistent with previous
reports (32).
Romo1 Induced Nuclear DNA
Damages—Because oxidative DNA
damage is sensed by the DNA dam-
age-response pathway and is known
to be a common mediator of senes-
cence (6), we examined whether
Romo1-triggered ROS induced DNA damage. Romo1-induced
DNA damage was examined by observation of the formation of
-H2AX foci. The production of -H2AX foci after irradiation
was confirmed by irradiating the IMR-90 cells with 10 Gy and
examining the foci using immunofluorescence microscopy
after staining the cells with the anti--H2AX antibody. As
shown in Fig. 5A, irradiation induced the formation of foci in
the nuclei of the IMR-90 cells. A similar observation was made
in the IMR-90 cells treated with H2O2. The IMR-90 cells were
then transfected with Romo1 to determine whether Romo1
induced the formation of -H2AX foci. The introduction of
Romo1 induced the formation of -H2AX foci, which was abol-
ished by NAC treatment, demonstrating that the ROS gener-
ated by Romo1 caused DNA damage (Fig. 5B). The Romo1-
induced formation of-H2AX foci formationwas confirmed by
treating the stably transfected H1299/pGene-Romo1 cells con-
taining anMFP-inducible expression system (29)withMFPand
counting the number of foci. As shown in Fig. 5C, MFP treat-
ment induced the formation of -H2AX foci. The -H2AX foci
began to form after 12 h and reached a maximum of 48 h after
the MFP treatment (Fig. 5D). The double strand breaks (DSBs)
generated by the Romo1-induced ROS were also examined
using a comet assay.As a positive control, the IMR-90 cellswere
irradiated, and the tail moment was analyzed (Fig. 6A). The tail
moment formed by Romo1-induced ROS was also observed in
theH1299/pGene-Romo1 cells treatedwithMFP (Fig. 6B). The
tail moment was detected from 12 h and increased in a time-
dependent manner (Fig. 6C).
FIGURE 3. Romo1-induced senescence of IMR-90 cells. A, retrovirus expressing Romo1 or H-Ras was
infected into IMR-90 cells and treated with G418 (200 g/ml). Acidic -galactosidase activity was meas-
ured after 10 days. B, senescent cells were counted under an invertedmicroscope. Results represent mean
(S.E.) of three independent experiments performed in triplicate. *, p  0.05 versus pLNCX2. C, Romo1-
induced ROS production. Cells were infected with retrovirus expressing H-Ras or Romo1 and stained with
DCF-DA. The level of ROS production was examined by confocal microscopy. The left column indicates
DCF-DA staining, and right column indicates the merged images of DCF-DA staining and MitoTracker
staining.
FIGURE 4. Inhibition of senescence progression by Romo1 knockdown.
After 1105 cells (PDL34)were seededonacoverglass in a6-well cell culture
plate, cells were transfected with control siRNA (40 nM) and Romo1 siRNA (40
nM) using Lipofectamine 2000. The cells were treated with 10 M NAC for 2 h
and repeated every 48 h. Romo1 siRNA was transfected into the cells, and
transfection was repeated again 4 days later. Ten days later, SA--galactosid-
ase assay was performed to estimate the senescence level. Result represents
mean (S.E.) of the three independent experiments performed in triplicate.
*, p 0.05.
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Romo1-derived ROS Originated from the Mitochondrial Res-
piratory Chain—Because Romo1 localizes to the mitochondria
(29), we examined whether Romo1-enhanced ROS production
originated from the mitochondrial respiratory chain. The
superoxide generation by Romo1 induction was observed by
MitoSOX, a mitochondrial superoxide indicator, staining. A
Romo1-inducible cell line (H1299/pGene-Romo1) was used in
this study. The cells were induced by MFP and treated with
specific inhibitors of the respiratory complexes. The levels of
ROS production were quantified by incubating the mitochon-
dria with MitoSOX. As shown in Fig. 7, A and B, ROS levels
were increased after Romo1 induction, and ROS production
was blocked by stigmatellin or myxothiazol treatment, which
inhibited ROS production at com-
plex III. Rotenone, an inhibitor of
the electron transport at complex I,
and malonate, a complex II inhibi-
tor, failed to inhibit ROS produc-
tion, suggesting that the Romo1-in-
duced production of ROS occurred
within complex III of the electron
transport chain. A previous study
showed thatmorphological changes
in themitochondria, in the formof a
round and swollen shape, were
observed in some of the Romo1-
GFP expressing H1299 cells (29).
These changes were also observed
by electron microscopy. As shown
in Fig. 7C, the intermembrane
spaces of many mitochondria ap-
peared to be widened. This mito-
chondrial structural reorganization
may be triggered by Romo1-in-
duced ROS production because
NAC treatment was shown to have
blocked the Romo1-induced mito-
chondrial cristae remodeling. An
increase in the levels of ROS in the
mitochondria may cause the open-
ing of the mitochondrial permeabil-
ity transition pore, resulting in the
collapse of the mitochondrial mem-
brane potential (m) (35). To test
whether Romo1-triggered ROS
production induced m changes,
the cells were treated withMFP and
stained with the m-sensitive dye
JC-1. As a positive control, the cells
were treated with H2O2. In H2O2-
treated cells, the JC-1 dye remained
in the cytoplasmic green fluores-
cence of the monomeric form, indi-
cating a low m (Fig. 7D). Fig. 7D
also indicates the merged image of
red fluorescence and green fluores-
cence, showing a yellow color. In-
creased Romo1 induction caused a
m, decrease and treatment with mitochondrial inhibitors
blocked any changes in m (Fig. 7D). These results dem-
onstrated that enhanced ROS levels induced by increased
Romo1 expression originated from complex III of the mito-
chondrial respiratory chain and that this may cause mito-
chondrial dysfunction.
DISCUSSION
Although ROS levels increased by various stresses could lead
to various pathological disorders, an appropriate ROS level is
indispensable for cell proliferation (4). The concentration of
H2O2 is intracellularly maintained from a low of	0.001 M to
a high of 	0.7 M (36). Antioxidant treatment inhibited cell
FIGURE5.Romo1 inducedDNAdamage in the IMR-90andH1299cells.A,-H2AX foci formation (red,middle
columns) in normal IMR-90 cells treated with either IR (10 Gy) or H2O2 (200 M) were examined by confocal
microscopy. DAPI, 4,6-diamidino-2-phenylindole. B, IMR-90 cells were transiently transfected with Romo1-
GFP, and the Romo1 expression levelwas examinedby confocalmicroscopy (left column, green). The increased
-H2AX foci formation (red, middle columns) was examined after Romo1 transfection. In the lower panels, the
decreased foci formation of -H2AX was examined in cells preincubated with NAC (0.5 mM). C, H1299/pGene-
Romo1 cells were treatedwithMFP (1 nM), and the increased formations of -H2AX foci (red fluorescence) were
examined. The decreased formation of-H2AX foci was examined in the cells preincubatedwithNAC (0.5mM).
D, time course analysis of DNA damage (-H2AX foci formation) in H1299/pGene-Romo1. The cells were
treated with MFP (1 nM), and the -H2AX foci in the cells were examined at 12, 24, and 48 h. The foci in at least
200 cells were counted, and the data represent themean ( S.E.) of three experiments performed in triplicate.
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growth by decreasing endogenous ROS levels (37). This cell
growth inhibition was because of the arrest of the cell in the G1
phase (38) resulting from the up-regulation of cyclin-depend-
ent kinase inhibitors, such as p21WAF/CIP1 and p16INK4a, and
down-regulation of G1 cyclins (39). Although treatment of the
cells with a high dose of H2O2 induced cell growth inhibition or
death, treatment of cells with a low dose of H2O2 increased cell
proliferation by activating the extracellular signal-regulated
kinase (40–42). In a previous study, we also showed that down-
regulation of ROS by Romo1 knockdown induced cell cycle
arrest at theG1 phase and inhibition of cyclinD1 expression (5).
Romo1 was first identified in 2006, and Romo1 expression
was shown to be up-regulated in most cancer cell lines (29). A
recent publication (43) reported that a high level of ROS
derived from the mitochondria was detected in cancer cells.
Therefore, we were curious to test if the high levels of ROS
observed in many cancer cells originated from Romo1 in our
previous study and showed that Romo1 knockdown decreased
ROS levels not only in various cancer cells but also in IMR-90
cells (5). This study demonstrated that Romo1-derived ROS
was needed for normal and cancer cell proliferation. However,
the exact mechanism of ROS production remains to be eluci-
dated. In subsequent experiments, we observed that Romo1
expression was increased in the IMR-90 cells with high PDL
and that its expression was up-regulated in proportion to
increasing PDL (Fig. 1A).Wewondered if Romo1-inducedROS
contributed to replicative senescence of IMR-90 cells. Because
ROS are themajor inducers of replicative senescence, and anti-
oxidant treatment was shown to delay the senescence of endo-
thelial cells (32), we tested whether Romo1-induced ROS
affected replicative senescence. Even though the expression of
Romo1was undetectable in IMR-90 cells byNorthern blot anal-
ysis (29), we were able to analyze the level of Romo1 expression
by RT-PCR (Fig. 2C). Romo1-derived ROS is indispensable for
normal cell proliferation because Romo1 siRNA transfection
inhibited IMR-90 cell growth (5). It appeared that Romo1,
which is expressed in low levels in normal cells, produced a
small amount of ROS needed for cell proliferation. Therefore,
we were unable to use a sufficient amount of Romo1 siRNA for
Romo1 knockdown in this study. We also observed that trans-
fection of 100 nM Romo1 siRNA twice for 10 days inhibited
growth of the IMR-90 cells (data not shown). In this study, low
amounts of Romo1 siRNA were transfected into IMR-90 cells,
such that severe growth inhibition was not induced. Although
replicative senescence of the cells transfected with 40 nM
Romo1 siRNA was partially delayed in Fig. 4, we suggest that
ROS derived from increased Romo1 expression plays an impor-
tant role in replicative senescence of IMR-90 cells.
It is known that ROS generated from the mitochondria are
major determinants of cellular senescence and organismal
aging (44). Mitochondrial function declines with aging. Low
m and increased ROS levels were observed in hepatocytes
from old rats (12, 13). In this study, we showed that enforced
Romo1 expression triggered cristae remodeling of mitochon-
dria and induced m down-regulation. Romo1 induced cris-
tae remodeling of the mitochondria, and m down-regula-
tion was triggered by ROS generated from Romo1 because
antioxidant treatment blocked Romo1-induced cristae remod-
eling of the mitochondria and m down-regulation. From
these results, we suggest that Romo1 expression is enhanced
during aging and that ROS levels derived by Romo1 causemito-
chondrial dysfunction, resulting in replicative senescence.
ROS levels, which cause single strand nicks and DSBs, are
up-regulated with age and can cause an increase in 8-oxo-dG
generation in various species (44). DSBs are often observed in
senescent cells and aged mice. Sedelnikova et al. (45) showed
that many DNA lesions with DSBs in senescent cells, which are
irreparable, were observed in nontelomeric regions and sug-
gested that persistentDNA lesionswith irreparableDSBs are an
important factor that causes aging. This study showed that ROS
produced by increased Romo1 expression induced nuclear
DNA damage. To accomplish this, ROS should be released into
the cytosol. Even though the majority of ROS in the mitochon-
dria are produced at complexes I and III, it has been reported
that complex III is a major source of ROS released into the
cytosol (46). Fig. 7 shows that stigmatellin and myxothiazol,
which inhibits the electron transport at complex III, blocked
Romo1-induced production of ROS. An analysis of a hypothet-
ical translation using the “Translate” program on the EXPASY
website indicated that Romo1 is a transmembrane protein.
FIGURE 6. Comet assay. A, comet assay was performed in the IMR-90 cells
infected with retrovirus expressing Romo1. As a positive control, the IMR-90
cells were irradiated with IR (10 Gy). B, comet assay was performed in the
H1299/pGene-Romo1 cells treated with MFP (1 nM). The H1299/pGene-
Romo1cellswere treatedwithMFP, and the time course analysis of the comet
assay was analyzed. C, length of the comet tail per length of the comet head,
which was defined as DNA damage, was measured in at least 80 cells per
sample. The data represent the mean (S.E.) of at least three independent
experiments performed in triplicate.
Romo1-induced Senescence
NOVEMBER 28, 2008•VOLUME 283•NUMBER 48 JOURNAL OF BIOLOGICAL CHEMISTRY 33769
 at Y
O
N
SEI U
N
IV
ERSITY
 on O
ctober 29, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Therefore, it is possible that Romo1 is located in themitochon-
drial membrane and that Romo1 plays an important role in
releasing ROS required for cell proliferation into the cytosol. It
should be noted that ROS levels are increased from aging and
various stresses and that they originate mainly from the mito-
chondria (3). We postulate that Romo1 expression is induced
during aging, and this enhancedRomo1 expression disturbs the
mitochondrial respiratory chain, resulting in the excessive gen-
eration of ROS. However, further studies will be needed to clar-
ify the exact mechanism by which Romo1 produces ROS and
contributes to replicative senescence.
In this study, we showed that increased Romo1 expression,
which is up-regulated in senescing human cells, contributes to
replicative senescence by producing ROS persistently and
inducing oxidativeDNAdamage. From the results of this study,
we suggest that Romo1 is one of the major molecular contrib-
utors toward ROS-associated aging. Further investigations will
be required to elucidate the exact mechanism by which Romo1
FIGURE 7.Blockage of Romo1-induced ROSbymitochondrial electron transport chain inhibitors. A, fluorescencemicroscopy images of Romo1-induced
ROS.H1299/pGene-Romo1 treatedwithMFP (1nM) for 24hwere cultured in thepresenceofNAC (1mM), stigmatellin (1M),myxothiazol (1M),malonate (100
M), or rotenone (1 M). After 1 h, the levels of ROS production were measured by fluorescence microscopy using MitoSOX. B, for quantification purposes,
exposures were collected for equal times at the same plane of focus. The imageswere overlaidwith a computer, andMitoSOX fluorescencewas analyzedwith
MetaMorph software (Universal Imaging,Westchester, PA). *,p 0.001.C,H1299/pGene-Romo1 cells treatedwithMFPwere culturedwith orwithoutNAC (0.5
mM) for 24 h. Themitochondrial structure of the cells was examined by transmission electronmicroscopy. Thewhite-boxed region shows a zoomedmitochon-
drial imageof the dashed box region. The arrows indicate themitochondriawith cristae remodeling. The scale bar represents 2m.D, fluorescencemicroscopy
images of Romo1-inducedmdecrease. The H1299/pGene-Romo1 cells were cells were inducedwithMFP for 24 h and cultured in the presence of NAC (0.5
mM), myxothiazol (1 M), or stigmatellin (1 M) for 30 min. As a positive control, the H1299 cells were treated with hydrogen peroxide (200 M) for 30 min.
Mitochondrialmembrane potential levelswere determinedusing JC-1 (5M) for 30min by confocalmicroscopy.Mitochondriawith lowmexhibited green
fluorescence. Merge represents the merged images with red plus green fluorescence. DAPI, 4,6-diamidino-2-phenylindole.
Romo1-induced Senescence
33770 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 48•NOVEMBER 28, 2008
 at Y
O
N
SEI U
N
IV
ERSITY
 on O
ctober 29, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
produces ROS formation. The functional role of Romo1 in
aging using an in vivo system also remains to be studied. Taken
together, our present data demonstrate a new molecule
involved in replicative senescence, which should be further
studied to understand the aging process.
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